Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-89
Closed -$4.31K 1027
2025
Q4
$4.31K Buy
+89
New +$4.41K ﹤0.01% 644
2025
Q1
Sell
-133
Closed -$6.42K 757
2024
Q4
$6.42K Buy
+133
New +$6.76K ﹤0.01% 515
2024
Q2
Sell
-872
Closed -$42.4K 669
2024
Q1
$42.4K Buy
872
+64
+8% +$3.13K 0.01% 294
2023
Q4
$40.2K Hold
808
0.01% 288
2023
Q3
$43.3K Hold
808
0.01% 268
2023
Q2
$43.6K Buy
+808
New +$43.5K 0.01% 279

Other funds holding SNY

Nemes Rush Group's SNY Position: Q1 2026 in Review

Nemes Rush Group sold out of Sanofi (SNY) in Q1 2026, closing a stake of 89 shares — an estimated $4.31K sold.

Nemes Rush Group first reported a position in SNY in Q2 2023 and held it in 6 quarters. The position peaked at $43.6K in Q2 2023. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Nemes Rush Group reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Nemes Rush Group sold 89 Sanofi shares in Q1 2026, an estimated $4.31K.
  • Nemes Rush Group first reported a position in Sanofi in Q2 2023 and held it in 6 quarters.
  • Nemes Rush Group's Sanofi position peaked at $43.6K in Q2 2023.
  • 745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.